Hu23F2G monoclonal antibody: Phase II Update

Icos Corp. (ICOS), Bothell,

Read the full 48 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE